Last reviewed · How we verify
Injection of autologous stem cells — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Injection of autologous stem cells (Injection of autologous stem cells) — Kenneth Peters, MD.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Injection of autologous stem cells TARGET | Injection of autologous stem cells | Kenneth Peters, MD | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Injection of autologous stem cells CI watch — RSS
- Injection of autologous stem cells CI watch — Atom
- Injection of autologous stem cells CI watch — JSON
- Injection of autologous stem cells alone — RSS
Cite this brief
Drug Landscape (2026). Injection of autologous stem cells — Competitive Intelligence Brief. https://druglandscape.com/ci/injection-of-autologous-stem-cells. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab